

Treatment-Resistant Depression (TRD): For individuals who have not achieved desired results after trying at least two antidepressant therapies.

Major Depressive Disorder (MDD) with Acute Suicidal Ideation or Behavior: A fast-acting option for those experiencing severe depressive symptoms.
Response Rate: Traditional antidepressants typically show a response rate of 40-60%, while Spravato® (esketamine) has demonstrated response rates of up to 70% in clinical trials (Popova et al., 2019, American Journal of Psychiatry).
Time to Noticeable Effect: Traditional antidepressants often take 4-6 weeks for noticeable improvements, whereas patients using Spravato® (esketamine) may experience relief within 24 hours, as observed in clinical trials (BMC Psychiatry, 2022).
Sustained Remission Rate: While conventional antidepressants typically result in sustained remission for only about 15% to 30% of patients, multiple studies suggest that Spravato®, when used alongside an oral antidepressant, may lead to remission rates averaging between 35% and 50%.



SPRAVATO® takes a novel approach to managing depression. Administered under the supervision of a healthcare provider, this nasal spray targets NMDA receptors in the brain, leading to quick and significant symptom relief. Patients receive SPRAVATO® in a certified SPRAVATO® anti-depressant treatment center in Jacksonville where they are closely monitored for at least two hours post-administration.


Begin with a complimentary phone consultation, followed by an in-depth evaluation by our mental health professionals. This includes reviewing your medical history and treatment needs to confirm eligibility for Spravato. If eligible, we verify your insurance coverage, working with major providers.

Once approved, your initial SPRAVATO® session is scheduled. Treatments are administered in our clinic under strict medical supervision. You self-administer the nasal spray in a calm, controlled environment and are monitored for at least two hours to ensure safety and address any side effects.

Your treatment plan begins with an induction phase, typically involving twice-weekly sessions. Over time, this transitions to a maintenance phase with less frequent treatments, customized to your unique mental health goals.

Our team remains by your side throughout your journey, offering regular follow-ups to monitor progress and address concerns. We adjust your treatment plan as needed, coordinate with your referring provider, and ensure you have the resources for sustained mental health improvement.

Week 1-4
2 Treatments a Week

Week 5-8
1 Treatments a Week

Week 9+
1 Treatment a Week Every 1-2 Weeks

Other clinics administer off-label ketamine solutions. At Altitude Health, we stay strictly with FDA-recommended treatments. Effective, safe, uplifting.

The setting — the place you actually receive treatments — is part of your healing process. It’s why our clinics are designed to be beautiful!

If you already have an existing mental health team, we want to ensure they’re in the loop — so you can receive the best possible care, all around.

If the cure involves high costs and paperwork, it’s not a cure. We only offer insurance-covered treatment — and we take care of the paperwork.
SPRAVATO® (esketamine) is an FDA-approved nasal spray designed for adults with treatment-resistant depression (TRD). Unlike traditional antidepressants that target serotonin and dopamine, SPRAVATO® works on NMDA receptors, helping to restore balance in brain function and providing relief for those who have not responded to standard treatments.
SPRAVATO® is intended for adults with treatment-resistant depression who have tried at least two different oral antidepressants without sufficient improvement. As of January 2025, the FDA has approved SPRAVATO® as a standalone treatment, meaning it no longer requires combination therapy with oral antidepressants. A consultation with a provider at Altitude Health will determine if SPRAVATO® is right for you.
Each session takes place in a comfortable, supervised setting at Altitude Health. You will self-administer the nasal spray under medical supervision. Afterward, you will be monitored for at least two hours for any potential side effects before being cleared to leave.
Many patients report feeling relief within 24 hours of their first few treatments. However, results vary, and a full treatment plan typically involves an induction phase (twice weekly for four weeks) followed by a maintenance phase based on your progress.
Common side effects include temporary dizziness, nausea, drowsiness, or dissociation (feeling detached from reality). These effects usually subside within a few hours. To ensure safety, patients are monitored closely during and after treatment.
No. Due to possible sedation and dissociation effects, you must arrange for someone to drive you home after each session. Patients should also avoid operating heavy machinery for the rest of the day.
The treatment schedule typically includes two sessions per week for the first four weeks, followed by a tapered maintenance phase depending on individual response. Your provider will tailor a plan based on your needs.
Most major insurance providers cover SPRAVATO®, but coverage varies by plan. Altitude Health’s team will assist you in verifying your benefits and minimizing out-of-pocket costs.
SPRAVATO® is FDA-approved for standalone use and covered by insurance, whereas IV ketamine infusions are often out-of-pocket expenses. Additionally, SPRAVATO® is administered as a nasal spray in a certified treatment center, while ketamine infusions require an IV.
To begin treatment, schedule a consultation with Altitude Health. Our team will evaluate your medical history, confirm eligibility, and create a personalized treatment plan to help you find relief from depression.
